These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8355773)

  • 1. Italian health sector in disarray following more scandals.
    Abbott A
    Nature; 1993 Aug; 364(6439):663. PubMed ID: 8355773
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH urged to cap profits made on publicly funded research.
    Macilwain C
    Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508
    [No Abstract]   [Full Text] [Related]  

  • 3. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 4. Clean drugs for Italy?
    Nature; 1993 Aug; 364(6439):658. PubMed ID: 8355770
    [No Abstract]   [Full Text] [Related]  

  • 5. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398
    [No Abstract]   [Full Text] [Related]  

  • 8. Revised drug policy.
    Shelat AJ
    J Indian Med Assoc; 1995 Mar; 93(3):117-8. PubMed ID: 8522818
    [No Abstract]   [Full Text] [Related]  

  • 9. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
    Toop L; Richards D; Saunders B
    N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
    [No Abstract]   [Full Text] [Related]  

  • 10. The sociology of pharmaceuticals: progress and prospects.
    Williams SJ; Gabe J; Davis P
    Sociol Health Illn; 2008 Sep; 30(6):813-24. PubMed ID: 18761505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Large scale "monitoring" for drug safety].
    Ghione M
    Boll Chim Farm; 1971 Oct; 110(10):573-8. PubMed ID: 5143355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Technical-administrative aspects of the registration of pharmaceutical specialities].
    Marconi M; Battaglino G
    Boll Chim Farm; 1979 Mar; 118(3):118-34. PubMed ID: 475904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circular no. 54 bis and Italian pharmaceutical research].
    Silvestrini B
    Boll Chim Farm; 1967 Jul; 106(7):439-42. PubMed ID: 5599307
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug price deal spells windfall for researchers.
    Bosch X
    Nature; 2001 Nov; 414(6860):138. PubMed ID: 11700514
    [No Abstract]   [Full Text] [Related]  

  • 15. New rules for US drug reimbursement.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
    [No Abstract]   [Full Text] [Related]  

  • 16. A tough market.
    Ridley-Smith RM
    N Z Med J; 2007 Aug; 120(1260):U2699. PubMed ID: 17726506
    [No Abstract]   [Full Text] [Related]  

  • 17. [Product innovation in the pharmaceutical sector. III.(II). The pharmaceutical sector].
    Cavara C
    Boll Chim Farm; 1991 Nov; 130(10):409-21. PubMed ID: 1805876
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines on the use of medicinal plants].
    Battaglino G; Quercia V
    Boll Chim Farm; 1978 May; 117(5):251-7. PubMed ID: 743374
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of patents for the qualitative level in the evaluation of drugs].
    Rovati AL
    Boll Chim Farm; 1971 Oct; 110(10):569-72. PubMed ID: 5143354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.